J, L., AM, S., MP, L., M, v. d. V., ME, M. G., JA, F., . . . JW, M. (2016). The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer. PloS one, 11(8), e0161731. https://doi.org/10.1371/journal.pone.0161731
Chicago Style (17th ed.) CitationJ, Liu, Sieuwerts AM, Look MP, van der Vlugt-Daane M, Meijer-van Gelder ME, Foekens JA, Hollestelle A, and Martens JW. "The 29.5 Kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer." PloS One 11, no. 8 (2016): e0161731. https://doi.org/10.1371/journal.pone.0161731.
MLA (9th ed.) CitationJ, Liu, et al. "The 29.5 Kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer." PloS One, vol. 11, no. 8, 2016, p. e0161731, https://doi.org/10.1371/journal.pone.0161731.